Bitech Technologies Past Earnings Performance
Past criteria checks 0/6
Bitech Technologies's earnings have been declining at an average annual rate of -0.01%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been declining at an average rate of 98.8% per year.
Key information
-0.007%
Earnings growth rate
40.5%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -98.8% |
| Return on equity | -633.2% |
| Net Margin | -263,536.7% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bitech Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 0 | -1 | 1 | 0 |
| 30 Sep 23 | 0 | -1 | 1 | 0 |
| 30 Jun 23 | 0 | -1 | 1 | 0 |
| 31 Mar 23 | 0 | -1 | 1 | 0 |
| 31 Dec 22 | 0 | -1 | 1 | 0 |
| 30 Sep 22 | 0 | -1 | 1 | 0 |
| 30 Jun 22 | 0 | -1 | 1 | 0 |
| 31 Mar 22 | 0 | -1 | 1 | 0 |
Quality Earnings: BTTC is currently unprofitable.
Growing Profit Margin: BTTC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BTTC's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare BTTC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BTTC is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).
Return on Equity
High ROE: BTTC has a negative Return on Equity (-633.21%), as it is currently unprofitable.